Multifamily Group Psychoeducation and Cognitive Remediation for First-Episode Psychosis: A Randomized Controlled Trial

BMC Psychiatry

Study Protocol

William R McFarlane¹  Rachele Peterson²  Seenaiah Byreddy²  Beth Bernstein³  Nicholas JK Breitborde³  Linda Durst³  Francisco A Moreno³  Natalie Mai-Dixon⁴ 

[1] Department of Psychiatry, Maine Medical Center, 295 Park Ave, 04102, Portland, Maine, USA;Department of Psychiatry, University of Arizona, 1501 N. Campbell Ave, PO Box 245002, 85724-5002, Tucson, AZ, USA;Department of Psychiatry, University of Arizona, 1501 N. Campbell Ave, PO Box 245002, 85724-5002, Tucson, AZ, USA;Department of Psychiatry, University Physicians Hospital, 2800 E. Ajo Way, 85713, Tucson, Arizona, USA;Department of Psychiatry, University of Rochester Medical Center, 601 Elmwood Ave, 14642, Rochester, New York, USA;

关键词: Family Caregiver;    Psychotic Disorder;    Caregiver Burden;    Cognitive Remediation;    Family Psychoeducation;   

DOI  :  10.1186/1471-244X-11-9

 received in 2010-12-12, accepted in 2011-01-12,  发布年份 2011

来源: Springer

【 摘 要 】

BackgroundMultifamily group psychoeducation (MFG) has been shown to reduce relapse rates among individuals with first-episode psychosis. However, given the cognitive demands associated with participating in this intervention (e.g., learning and applying a structured problem-solving activity), the cognitive deficits that accompany psychotic disorders may limit the ability of certain individuals to benefit from this intervention. Thus, the goal of this study is to examine whether individuals with first-episode psychosis who participate simultaneously in MFG and cognitive remediation--an intervention shown to improve cognitive functioning among individuals with psychotic disorders--will be less likely to experience a relapse than individuals who participate in MFG alone.Methods/DesignForty individuals with first-episode psychosis and their caregiving relative will be recruited to participate in this study. Individuals with first-episode psychosis will be randomized to one of two conditions: (i) MFG with concurrent participation in cognitive remediation or (ii) MFG alone. The primary outcome for this study is relapse of psychotic symptoms. We will also examine secondary outcomes among both individuals with first-episode psychosis (i.e., social and vocational functioning, health-related quality of life, service utilization, independent living status, and cognitive functioning) and their caregiving relatives (i.e., caregiver burden, anxiety, and depression)DiscussionCognitive remediation offers the possibility of ameliorating a specific deficit (i.e., deficits in cognitive functioning) that often accompanies psychotic symptoms and may restrict the magnitude of the clinical benefits derived from MFG.Trial RegistrationClinicalTrials (NCT): NCT01196286

【 授权许可】

CC BY   
© Breitborde et al; licensee BioMed Central Ltd. 2011